We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App

Bracco Features its Mission of 'No Compromise in MRI' at RSNA 2022

By MedImaging International staff writers
Posted on 25 Nov 2022
Print article
Image: The FDA-approved Gadopiclenol injection will be commercialized as VUEWAY (Photo courtesy of Bracco)
Image: The FDA-approved Gadopiclenol injection will be commercialized as VUEWAY (Photo courtesy of Bracco)

Bracco Diagnostics Inc. (Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., is featuring the recently FDA-approved Gadopiclenol Injection, a novel, highly stable macrocyclic gadolinium-based contrast agent (GBCA), commercialized as VUEWAY (gadopiclenol) injection by Bracco, among a robust line of imaging products, devices, and support solutions, at RSNA 2022.

Bracco is offering several engagement opportunities at RSNA 2022, including Meet and Connect with Peers during a media briefing that will profile 'No Compromise in Magnetic Resonance Imaging (MRI),' to summarize the company's comprehensive support and education, and spotlight the new category that VUEWAY injection creates for imaging agents. Bracco is also offering ‘Celebrate our Leaders on the Horizon’, an exclusive radiology residency program in which continuing education scholarships are awarded to five radiology residents whose submitted research papers are selected for publication in a special supplement to Applied Radiology. Visitors to the Bracco booth can experience its innovation throughout all diagnostic imaging modalities, including its Smartinject contrast delivery platforms, innovative informatics solutions, and best-in-class service offerings.

“We can think of no better venue to further educate and connect with our peers and industry partners than at RSNA, the world's largest medical imaging forum,” said Cosimo De Pinto, Senior Vice President, Sales and Marketing at Bracco Diagnostics Inc. “We've taken this year's congress theme of 'empowering patients and partners in our care' to heart, working hard to ensure our customers can look deeper and remain confident in the care they provide their patients. We are united in driving forward the next generation of diagnostic solutions as we unveil VUEWAY injection and work to fulfill our own mission of 'No Compromise in MRI'.”

Related Links:
Bracco Diagnostics Inc.

Gold Member
Solid State Kv/Dose Multi-Sensor
Imaging Table
Stille imagiQ2
Portable X-Ray Unit
Ultrasound Doppler System
Doppler BT-200

Print article



view channel
Image: The study supports annual screening beginning at age 40 as the best way to diagnose cancer early (Photo courtesy of 123RF)

Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%

Breast cancer remains a leading cause of cancer-related deaths among women in the United States. Although studies have shown that regular mammography screenings can cut breast cancer fatalities by 40%,... Read more


view channel
Image: Researchers have created a new MRI brain extraction tool for neonates (Photo courtesy of 123RF)

Deep Learning Algorithm Performs Automatic Segmentation of Neonatal Brains from MR Images

Magnetic Resonance Imaging (MRI) is a vital tool in medical diagnostics, particularly because of its high-resolution images and superior soft tissue contrast, which make it crucial for brain evaluations.... Read more


view channel
Mindray`s comprehensive range of ultrasound machines include the Resona I9 (photo courtesy of Mindray)

Non-Invasive Ultrasound Technique Helps Identify Life-Changing Complications after Neck Surgery

Nasopharyngoscopy is an intrusive diagnostic medical procedure that involves the examination of the internal structures of the nose and throat (nasopharynx) using an endoscope inserted through the patient’s nose.... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: The new AI-enabled CT 5300 aims to bring confident diagnosis to more patients at low cost (Photo courtesy of Royal Philips)

AI-Enabled CT System Provides More Accurate and Reliable Imaging Results

Computed Tomography (CT) plays a critical role in diagnosing cardiac diseases. Recent research advocates a "CT first" approach for patients with chest pain and undiagnosed coronary artery disease, thus... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.